Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, +28

Nature Immunology

Long CovidCovid-19 PandemicImmunologyHumoral ImmunityCovid-19 Clinical Spectrum +3

The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles

Bertrand Boson, Vincent Legros, Bingjie Zhou, +5

Journal of Biological Chemistry

Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines

Aurélie Ploquin, Judit Szécsi, Cyrille Mathieu, +7

The Journal of Infectious Diseases

VaccinationVeterinary VaccineVaccine DevelopmentAllergyVaccine Target +9

Nipah Virus Uses Leukocytes for Efficient Dissemination within a Host

Cyrille Mathieu, Christine Pohl, Judit Szécsi, +7

Journal of Virology

Type I Interferon Signaling Protects Mice From Lethal Henipavirus Infection

Kévin P. Dhondt, Cyrille Mathieu, Marie Châlons, +4

The Journal of Infectious Diseases

Host ResponseMolecular VirologyNipah VirusPathogenesisImmunology +9

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

Maxime Espi, Xavier Charmetant, Thomas Barba, +64

Kidney International

VaccinationVaccine SafetyHemodialysisMedicineImmunology +8

A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity

Antonello Pessi, Annunziata Langella, Elena Capitò, +9

PLoS ONE

Nonstructural Nipah Virus C Protein Regulates both the Early Host Proinflammatory Response and Viral Virulence

Cyrille Mathieu, Vanessa Guillaume, Valentina A. Volchkova, +8

Journal of Virology

Viral PathogenesisImmunologyPathologyNiv CInnate Immunity +16

Fatal Measles Virus Infection Prevented by Brain-Penetrant Fusion Inhibitors

Jérémy Welsch, Aparna Talekar, Cyrille Mathieu, +4

Journal of Virology

Synthetic VirologyMedicineImmunologyAntiviral ResponseTherapeutic Vaccine +13

Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19

Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, +25